# A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

> **NCT04009876** · PHASE2 · COMPLETED · sponsor: **Fundación de investigación HM** · enrollment: 30 (actual)

## Conditions studied

- Locally Advanced Rectal Cancer (LARC)

## Interventions

- **DRUG:** nal-IRI
- **PROCEDURE:** Surgical resection
- **OTHER:** Watch-and-wait
- **DRUG:** 5-FU/LV
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT04009876
- **Lead sponsor:** Fundación de investigación HM
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2022-10-21
- **Final completion:** 2022-10-21
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04009876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04009876, "A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04009876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*